Eleanor Landwehr, PhD
Doctoral Dissertation: Syntheses of Galbulimima Alkaloids from High Fraction sp2 Starting Materials
Research Focus: Eleanor synthesized several GB alkaloids from high fraction sp2, commercially available starting materials. Gram-scale access to these bioactive molecules has allowed for modern biological evaluation of their properties.
Undergraduate Institution: University of Wisconsin-Madison
Noteworthy Publications: Concise syntheses of GB22, GB13, and himgaline by cross-coupling and complete reduction, Science (2022)
Honors and Awards: Christopher T. Walsh Endowed Graduate Student Fellowship in the Skaggs Graduate School of Chemical and Biological Sciences
Looking Back: "I couldn’t have completed graduate school without the support of my friends and family, especially my lab mates. When I started it was the beginning of the pandemic, and I had just moved to this new place and started this new journey. The support and friendship that I received in those first years is something I’ll never forget. Now as we have all moved away, I’m grateful for our lifelong friendships that look a little different than our time in adjoining fume hoods but feel just as important."
What's Next: "I am currently working in discovery chemistry at Johnson & Johnson in La Jolla."
Join us at 10 a.m. PDT on Friday, May 16, 2025 for our Commencement Ceremony Livestream! Landwehr will be introduced by her advisor, Prof. Ryan Shenvi, who will deliver a few words about her graduate experience. Viewers will also learn about our many other 2025 graduates, who are now setting out to build careers that will profoundly impact the future of biomedical research.
